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Abstract
Background: Intensity-modulated radiotherapy (IMRT) may allow improvement in plan quality for treatment of
liver cancer, however increasing radiation modulation complexity can lead to increased uncertainties and
requirements for quality assurance. This study assesses whether target coverage and normal tissue avoidance can
be maintained in liver cancer intensity-modulated radiotherapy (IMRT) plans by systematically reducing the
complexity of the delivered fluence.
Methods: An optimal baseline six fraction individualized IMRT plan for 27 patients with 45 liver cancers was
developed which provided a median minimum dose to 0.5 cc of the planning target volume (PTV) of 38.3 Gy
(range, 25.9-59.5 Gy), in 6 fractions, while maintaining liver toxicity risk <5% and maximum luminal gastrointestinal
structure doses of 30 Gy. The number of segments was systematically reduced until normal tissue constraints were
exceeded while maintaining equivalent dose coverage to 95% of PTV (PTVD95). Radiotherapy doses were
compared between the plans.
Results: Reduction in the number of segments was achieved for all 27 plans from a median of 48 segments
(range 34-52) to 19 segments (range 6-30), without exceeding normal tissue dose objectives and maintaining
equivalent PTVD95 and similar PTV Equivalent Uniform Dose (EUD(-20)) IMRT plans with fewer segments had
significantly less monitor units (mean, 1892 reduced to 1695, p = 0.012), but also reduced dose conformity (mean,
RTOG Conformity Index 1.42 increased to 1.53 p = 0.001).
Conclusions: Tumour coverage and normal tissue objectives were maintained with simplified liver IMRT, at the
expense of reduced conformity.
Background
Conformal liver radiotherapy (CRT) has an emerging
role in treating unresectable primary or metastatic can-
cer in the liver. Conventional and hypofractionated
stereotactic body radiotherapy (SBRT) results in low
reported rates of toxicity and high tumour control rates
for both primary and metastatic liver cancer [1-3]. The
majority of trials have treated small lesions typically <5
cm in size; however treatment of larger, multifocal
tumours can be performed safely as long as doses are
individualized to avoid liver and other normal tissue
toxicity[1-3]. CRT planning for large multifocal tumours
is challenging, and intensity modulated radiotherapy
(IMRT) has the potential for improving the treatment of
liver cancer, by facilitating dose escalation particularly
for large tumours and/or reducing dose to normal tis-
sues[4,5]. However the potential improvements in plan
quality have to be considered against the potential draw-
backs of more complex radiotherapy plans including
increasing requirements for quality assurance checks
and risks of errors in treatment delivery.
IMRT can improve radiation plan quality by use of
mathematical and biological cost function algorithms to
optimize the planned radiation dose distributions, not
easily performed using non-automated forward planned
segmented CRT[6]. Liver IMRT planning studies have
typically used complex highly modulated plans with the
number of segments used up to 100 segments per beam
or 10 intensity levels[5,7,8]. However, increasing IMRT
radiation fluence complexity is not beneficial for all liver
cancers, and treatment of smaller lesions may benefit
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many beams and beam angles, as opposed to increasing
IMRT modulation complexity[9].
The dosimetric benefit of IMRT plans with increasing
number of beam segments appears to have a ceiling,
with prior studies on non-liver IMRT showing reducing
gains when using more than 5-9 segments per beam[10]
or more than 5 intensity levels[11]. More complex
highly segmented or modulated IMRT plans have the
potential disadvantages of; 1) delivery of more treatment
monitor units (MUs) with a resulting increase in treat-
ment time (presuming a constant machine dose rate)
[12]; 2) increased leaf leakage with potentially increased
risks of second malignancy[13,14]; 3) increased sensitiv-
ity to geometric uncertainties and; 4) decreased dosi-
metric accuracy of IMRT delivery with potentially more
time needed for accurate dosimetric quality assurance
[14]. That is, more complex IMRT modulated plans
may result in larger differences between the nominal
and delivered doses for tumour and normal tissues.
Thus, there is motivation to reduce complexity of IMRT
plans if safely possible.
Image guided radiotherapy (IGRT) and motion man-
agement strategies can reduce the residual geometric
uncertainties (and improve the concordance between
the nominal and delivered doses). However IGRT solu-
tions are not always available and residual geometric
error will always exist, for example due to intra-fraction
organ motion, deformation, change in position of
organs, tolerance levels for repositioning patients, etc
[15]. Dosimetric inaccuracy with radiation planning can
result in up to 13% underestimation of dose delivered
occurring in highly modulated regions of an IMRT field,
[16] and single beam daily dose variations in the order
of 15 to 35% in the presence of breathing motion,
potentially resulting in systematic errors in dose calcula-
tions[17,18]. More complex IMRT plans with low
weighted segments (e.g. 10-15 MUs per segment) and
more segments are more susceptible to these effects,[19]
with a potentially larger clinical impact for hypofractio-
nated radiotherapy[18].
Due to the increased uncertainties that exist between
the nominal and delivered doses for more complex
IMRT plans than less complex plans, a strong rationale
exists to investigate and use IMRT plans with simple
modulation if more complex plans do not significantly
improve the plan quality. Thus, a planning study was
developed to simplify the radiation modulation pattern
by using fewer beam segments in liver IMRT. The aim
of this study was to determine the minimum number of
planned segments in liver IMRT plans that could main-
tain adequate target coverage and normal tissue dose
objectives.
Methods
Study Design
T h ep r i m a r yo b j e c t i v ew a st od e t e r m i n ei fm o r et h a n
80% of IMRT plans could be simplified, by using 30 or
less beam segments, without a clinically significant com-
promise of target coverage or normal tissue sparing. A
sample size of 27 cases was required to obtain an exact
95% confidence interval that more than 80% of simple
IMRT plans would be acceptable (i.e. in 25 or more of
27 cases, the simplified IMRT plans would be clinically
acceptable and meet tumor coverage and normal tissue
sparing guidelines). This was deemed to be a clinically
significant number of plans in which we would recom-
mend treating patients with an IMRT plan using simpler
beam modulation as compared to a plan with complex
beam modulation. Secondary objectives were to assess
the changes in number of MUs delivered, target dose
conformity, and differences in doses delivered to normal
structures, compared to index IMRT plans using many
segments.
Plans were developed from 27 planning CT datasets
from patients previously treated on a research ethics
board approved phase I and II clinical trials for primary
and metastatic liver cancer, of 6 fraction, individualized
CRT treated with daily IGRT[20]. Unlike most SBRT
experience, these studies allowed patients with large and
multifocal cancers to be treated, and the prescription
dose was often limited by normal tissue tolerances
[2,3,20]. Initially 10 patients were selected from a patient
cohort in which dosimetric benefits of IMRT compared
to CRT were previously demonstrated[4]. Another 17
cases with prescription doses limited by risk of normal
tissue toxicity (adjacent luminal structures or liver toxi-
city) were also included, as they were the types of liver
cases previously found to most likely to benefit from
IMRT (vs. CRT)[4].
Index IMRT planning
An index, segmented IMRT plan was generated and
evaluated for each case using Pinnacle, version 8.0,
treatment planning system (ADAC, Milpitas, CA). Plan
optimization was performed using direct machine para-
meter optimization (DMPO), a method of direct aper-
ture optimization that allows the maximum number of
IMRT segments to be specified prior to plan optimisa-
tion[21]. The index IMRT plans were optimized to have
a maximum of 50 segments, although 1 plan had up to
52 segments as an optimized plan from the initial IMRT
planning cohort [4]. The index IMRT plan was deter-
mined as the one that delivered the highest minimum
dose to 0.5 cc of the PTV while maintaining normal tis-
sues constraints resulting in some index plans having
fewer than 50 segments.
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Page 2 of 9An exhale breath-hold helical CT was used for treat-
ment planning, and presumption of use of a breath-hold
device during treatment was made for the purposes of
this study, to remove the potential adverse impact of
breathing motion. Gross tumour volumes (GTVs) and
organs at risk (OARs) (e.g. liver, oesophagus, stomach,
duodenum, bowel, heart, ribs and spinal cord) were deli-
neated on the exhale breath-hold CT scan. A uniform
5 mm expansion around the GTVs was used to create
the planning target volume (PTV)[15].
The index IMRT plans had more than 30 beam seg-
ments (maximum 52) and used 3 to 8 beams (median 5)
with up to 2 non-coplanar beam angles. Individualized
beam angles similar to those used in the clinical radia-
tion plan (chosen by experienced planners) were used.
These beam angles were typically chosen to spare the
maximum volume of normal liver irradiated to minimise
the risk of radiation induced liver disease, however
other beam angles are also chosen to create steep radia-
tion gradients near adjacent normal visceral structures.
A minimum segment area of 2 cm
2 with a segment
width of 1 cm and 10 MUs per segment were specified.
Beam energies of 6 MV or 10 MV, a 2.5 mm dose grid
and a convolution/superposition algorithm for dose cal-
culation were used.
The radiation dose prescription was individualized
between patients and was based on the dose covering
95% of the PTV (PTVD95). Plans were optimized to
provide the highest, minimum dose covering 0.5 cc of
the PTV while maintaining normal structure dose con-
straints (table 1). A maximum prescription dose of 60
Gy for metastases and 54 Gy for primary HCC, in 6
fractions, was specified. Hot spots were limited to 120%
outside PTV and 140% inside the PTV. A maximum
liver normal tissue complication probability (NTCP) of
5% was permitted, based on the Lyman-Kutcher-Burman
(LKB) NTCP model[22,23], using parameters based on
the data published from the University of Michigan[24],
with biological corrections for dose per fraction using
an a/b correction of 2.5 Gy[20].
Generalized equivalent uniform dose (gEUD) was used
for plan optimization to limit the dose received by the
liver[25]. The gEUD also allows heterogeneous doses
within a normal structure or volume to be represented
as a single equivalent dose which can be weighted differ-
ently towards the maximum or minimum dose delivered
to a structure. It is useful in analysing heterogeneous
dose distribution over a target particularly in the setting
of IMRT or conformal radiotherapy plans. To assess the
effect of heterogeneous doses within the PTV, an
equivalent uniform dose with an ‘a’ value of -20 was
used (EUD(-20)), this value would reflect an aggressive
tumour that would be more sensitive to low doses
within the PTV[4,6].
Reduced Segment (Simple) IMRT
The total number of segments used in the IMRT opti-
mization was systematically reduced to the minimum
number which resulted in an “acceptable” simple IMRT
plan based on the criteria from table 1, while maintain-
ing a minimum dose to 0.5 cc of PTV, within 0.6 Gy of
the index IMRT plan. This acceptance criteria was cho-
sen to be consistent with dosimetric accuracy estimated
to be 2% of a 30 Gy plan (for a variation of 0.6 Gy) (Fig-
ure 1). The number of segments was altered with each
re-optimization of IMRT. All plans were then renorma-
lized to the minimum dose covering 95% of the index
I M R T ,a n dt h e yh a dt om e e tt h en o r m a lt i s s u ec o n -
straints specified. Otherwise a plan with more segments
was chosen as the simplest acceptable IMRT plan.
Evaluation
Number of segments and treatment MUs were com-
pared between simple and index IMRT plans. Plan con-
formity was assessed using the RTOG conformity index
(RTOG CI), we defined the relevant doses as the quoti-
ent of the total isodose volume of the minimum dose
c o v e r i n g0 . 5c co ft h eP T Vo nt h ei n d e xp l a na n d
Table 1 Six Fraction IMRT Planning Dose Limits
Structure Dose Limit
Liver 5% Normal Tissue Complication Probability
Esophagus Maximum 30 Gy to 0.5 cc
Stomach Maximum 30 Gy to 0.5 cc
Bowel Maximum 30 Gy to 0.5 cc
Cord Maximum 25 Gy
Ribs Maximum 48 Gy to 0.5 cc
Heart Maximum 45 Gy to 0.5 cc
Kidney Mean kidney doses <10.8 Gy
Target Volume Maximum dose 140% of prescription
Index IMRT
Unacceptable
Re-plan with more 
segments
Acceptable
Plan with
fewer segments
Simple
IMRT Plan
(fewest segments)
Minimum PTV
dose +/- 0.6Gy
of index IMRT
Renormalized to 
equivalent minimum
dose to 95% of PTV
Figure 1 Schematic of Intensity Modulated Radiotherapy
Segment Number Reduction.
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were compared, as a measu r eo fh i g hd o s e( 4 2G y ) ,
moderate dose (30 Gy) and low dose (1 Gy) conformity.
Additionally integral dose was assessed as the joules (J)
received to the treatment volume outside of the PTV
based on the calculated doses from the treatment plan-
ning system. Assumptions were made that the density of
tissue in the irradiated volume was 1 g/mL and is used
to compare the potential impact of lower doses deliv-
ered to larger volumes by more complicated modulated
radiotherapy.
Summary statistics were analyzed for minimum PTV
dose to 99% (PTVD99), PTVD95, 0.5 cc of the PTV and
the PTV EUD (-20). Normal liver (liver minus GTV),
rib, heart, spinal cord and gastrointestinal visceral struc-
ture maximum and mean doses were assessed. The
effective liver volume (Veff )i r r a d i a t e dw a su s e da sa
measure of volume of normal liver irradiated[22].
A novel in-house complexity metric for IMRT was also
used to assess plans[26]. In brief, this complexity metric
is calculated based on three parameters that are indepen-
dent of the segment number: the relative segment weight,
the segment area and the position of the multi-leaf colli-
mator (MLC) defining the segment shape. A simple plan
would have the least amount of beam modulation (i.e.
one open beam aperture) with the highest score of 1, and
a complex IMRT plan would have a low score closer to 0.
This metric is associated with the dosimetric accuracy
between the planned and actual delivered dose of an
IMRT plan, as reported by McNiven et al. [26]
Statistics
Analyses were performed using SPSS version 16. Wil-
coxon signed ranked tests were performed to test for
statistical differences in doses for the primary outcomes.
Exploratory analysis and secondary outcomes was per-
formed using forward multivariate linear regression,
Mann-Whitney and Kruskal-Wallis tests for non-
parametric data. For statistical analysis, a two sided p-
value of <0.05 was considered significant. No corrections
for multiple analyses were performed for secondary ana-
lyses. P values were used to help indicate possible asso-
ciations of between IMRT plans and dose relationships.
Results
Tumour/planning characteristics
Eleven patients with primary liver cancer and sixteen
with liver metastases having a total of 45 liver tumours
(tumours per patient range: 1 - 5) were included in this
planning study. Dose escalation was limited by adjacent
OARs and/or risk of liver toxicity in 24 of the 27
patients (table 2).
In all patients, an “acceptable” simple IMRT plan with
≤30 beam segments was achieved without exceeding
normal structure dose constraints or clinically compro-
mising PTV coverage. The number of beam segments
for the simplest acceptable IMRT plans (median 19;
range: 6-30) was significantly less than number of beam
segments in the index IMRT plan (median 48; range 34-
52), p < 0.001. The 95% confidence interval (adjusted
wald) of acceptable simple IMRT plans that could be
obtained using 30 beam segments or less is 85.2% to
100%.
There was little correlation between the tumour num-
ber, volume, number of beams or index plan complexity
and minimum number of IMRT segments associated
with plan acceptability on multivariate analysis (maxi-
mum model R
2 = 0.127).
The total number of plan MUs was significantly lower
with simple IMRT (mean 1695 MUs vs. 1892 MUs, p =
Table 2 Patient Characteristics
Total Dose Limiting Structure
None Liver Non-Liver OARs Liver & other OARs
Number 27 3 5 10 9
Diagnosis
Metastases 17 2 1 9 5
Hepatocellular 10 1 4 1 4
Tumor Number
Mean 1.7 1 1.6 2 1.6
Range 1-5 1 1-3 1-5 1-3
Tumor Volume, cc
Mean 211.6 11 283 150.4 306.6
Range 4.2-756 6.7-13.8 16.9-707 4.2-394.1 52.4-756
Prescription, Gy
Mean 42.4 57 42.9 39.4 40.5
Range 28.1-60 55.3-60 32.6-55.3 28.8-54.4 28.1-55.3
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Page 4 of 90.012), with significantly more MUs delivered per seg-
ment (mean 106 MUs/segment vs. 40 MUs/segment,
p < 0.001).
Target Coverage
There was no overall differences seen in the PTVD95 or
PTV EUD (-20) between the simple and index IMRT
plans (mean 44.6 Gy vs. 44.5 Gy, p = 0.066). As
expected, the dose to 0.5 cc of the PTV was statistically
less for simple IMRT compared to index IMRT (mean
39.5 Gy vs. 40.0 Gy, p0.006), as was PTVD99 (mean
40.6 Gy vs. 41 Gy, p < 0.001) (figure 2), since small dif-
ferences in minimum dose to 0.5 cc of PTV were per-
mitted in the study design and likely of little clinical
significance as summarized in table 3. The maximum
doses within PTV were higher for the simple IMRT
compared to index IMRT (mean 123.4% vs. 121.3%,
p = 0.036).
Normal Tissue Dose
Maximum dose delivered to the heart (mean 25.3 Gy vs.
24.5 Gy, p = 0.048) and ribs (mean 38.7 Gy vs. 37.7 Gy,
p = 0.044) was significantly higher for simple IMRT (fig-
ure 3) but no other statistically significant differences
were seen in other OARs, liver Veff, biological liver
NTCP or mean liver dose. Examples of simple IMRT
and index IMRT plans are shown in figure 4.
RTOG CI was significantly higher (poorer dose con-
formity) for simple IMRT than index IMRT (mean 1.52
vs. 1.42, p = 0.001, figure 5a) with similar differences for
plans with prescription dose ≥ 42 Gy (mean 1.33 vs.
1.45, p = 0.026) or < 42 Gy (mean 1.52 vs. 1.60,
p = 0.007), demonstrating reduced conformality in the
simple IMRT plans. This was also reflected in larger iso-
dose volumes outside PTV for 42 Gy (mean 74 vs. 63
mL, p = 0.025), 30 Gy (mean 364 vs. 323 mL, p = 0.003)
but not for 1 Gy (mean 8220 vs. 8271 mL, p = 0.517) or
integral dose (69.1 J vs. 68.7 J (p = 0.374)). Using multi-
variable linear regression, the sole factor that statistically
correlated with a higher RTOG CI in simple and index
IMRT was number of tumours in the liver (p = 0.004,
adjusted R
2 = 0.26 and p = 0.047, adjusted R
2 = 0.115
respectively) as seen in figure 5b.
Plan Complexity
Simple IMRT had a significantly reduced complexity
compared to the index IMRT using the complexity
metric (mean 0.63 vs. 0.51, p < 0.001). Only number of
MUs had a consistent correlation with the complexity
score using forward linear regression (R
2 =0 . 5 2f o r
whole group, 0.51 for simple plans and 0.56 for index
plans, p < 0.001).
Discussion
This study investigated simplification of IMRT planning
for a heterogeneous group of liver cancers (e.g. with
high tumour volume and location variability) by redu-
cing the number of IMRT segments and measuring the
impact on dose to target and normal tissue volumes. To
allow a direct comparison of the effects of reduced seg-
ment IMRT plans compared to index, more complex,
IMRT plans, similar IMRT planning parameters were
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Page 5 of 9used for both situations (i.e. number of beams and
angles, minimum segment size and minimum segment
monitor units), while only the IMRT segment number
was adjusted for plan optimization. Beam angles were
chosen based on the angles used clinically for each
patient, removing the impact of beam number and
beam angle from the comparison. All liver cancers in
t h i ss t u d yw e r ea b l et ob ep l a n n e du s i n g3 0o rf e w e r
segments without exceeding normal tissue constraints
while maintaining PTV coverage, showing that it is fea-
sible to treat patients with liver cancer using IMRT with
relatively few beam segments. The main compromise
Table 3 Differences between Nominal Index and Simple IMRT plans
Structure Index IMRT Mean [Range] Simple IMRT Mean [Range] p-value
Segment Number* 47 [34-52] 18 [6-30] <0.001
Complexity Score 0.51 [0.2-0.72] 0.63 [0.35-0.85] <0.001
RTOG CI 1.42 [0.99-2.02] 1.52 [1.11-2.21] 0.001
Monitor Units 1892 [953-3761] 1695 [934-3832] 0.012
PTV D95 (Gy) 42.4 [28.1-60.7] 42.4 [28.1-60.8] 0.197
PTV D99 (Gy) 41.0 [27.3-58.7] 40.6 [27.2-58.7] <0.001
PTV Min. 0.5 mL (Gy) 40.0 [25.7-59.4] 39.5 [25.7-59.5] 0.006
PTV EUD (-20) (Gy) 44.5 [29.4-63.9] 44.6 [29.6-64.6] 0.066
Liver NTCP (%) 2.7 [0-5] 2.4 [0-5] 0.370
Effective Liver Volume 0.38 [0.07-0.7] 0.38 [0.07-0.71] 0.418
Mean Liver Dose (Gy) 15.1 [2.4-20.2] 15.1 [2.7-19.8] 0.809
Mean Kidney Dose (Gy) 3.3 [0-13.7] 3.4 [0.3-11.7] 0.509
Max. Cord Dose (Gy) 16.4 [2.6-24] 16.2 [2.3-24.8] 0.713
Max.Stomach Dose (Gy) 19.6 [1.1-30] 19.4 [0.6-30] 0.548
Max. Duodenum Dose (Gy) 10.1 [0-29.9] 9.9 [0-29.4] 0.648
Max. Bowel Dose (Gy) 9.9 [0-30] 9.7 [0-30] 0.545
Max. Esophagus Dose (Gy) 16.1 [0-30] 16.1 [0-29.6] 0.980
Max. Heart Dose (Gy) 24.5 [0-43.9] 25.3 0.048
Max. Ribs Dose (Gy) 37.7 [0-48] 38.2 [0-48] 0.044
Integral Dose (J) 68.7 [4.7-181.6] 69.1 [5.2-173.9] 0.374
* primary endpoint for analysis
Max. is maximum dose to 0.5 mL of relevant structure except for cord where the point maximum dose is reported.
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Page 6 of 9seen when using fewer planned segments was a loss in
the plan conformity, resulting in higher doses of radia-
tion being delivered to some normal structures. This is
l i k e l yt ob em o r ei m p o r t a n ta st h ep r e s c r i p t i o nd o s e
increases (e.g. small typical SBRT tumours treated with
doses >48 Gy in 6 fractions); in this setting use of more
treatment beams/angles is likely to be more beneficial
than only increasing IMRT radiation modulation in an
attempt to improve the dose conformity and reduce the
potential for undefined late toxicity in high dose regions.
These were the minority of cases studied here, as the
larger more complex tumours, most likely to benefit
from IMRT often have their prescription dose limited
by normal tissue limits[4,7]. In these more challenging
liver cancer cases, developing a segmented CRT plan
manually is not efficient. Use of IMRT with few seg-
ments can potentially maximize the benefits of treat-
ment planning efficiency and improved dose conformity
without the increased sensitivity of complex IMRT to
geometric and dosimetric uncertainties. This may poten-
tially result in the best balance between the benefits of
CRT using few numbers of segments and complex mul-
tiple segmented IMRT.
The main motivation for studying less complex IMRT
in this study was to reduce the negative impact of dosi-
metric and geometric uncertainties associated with more
complex IMRT, in the upper abdomen. Potentially this
can also reduce the risk of errors in calculating radiation
dose and consequent time taken to perform quality
a s s u r a n c eo fm o r ec o m p l e xIMRT plans. Delivered
doses are less well correlated with planned doses in the
A 40 Segments 6 Segments 40 Segments 6 Segments
B 49 Segments 17 Segments 49 Segments 17 Segments 28Gy
30Gy
10Gy
57Gy
30Gy
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40Gy
Index Plan Simple Plan Index Plan Simple Plan
Figure 4 Axial (left panels) and Coronal (right panels) slices of acceptable index and simple IMRT, showing the six fraction, lowest
isodose covering 0.5 cc PTV (orange), the 30 Gy isodose (dark blue) and 10 Gy isodose (beige) surrounding the PTV (pink colorwash).
Examples are shown of a small lesion typical of liver SBRT (A), where loss of dose conformation of higher isodoses may have larger effects on
normal tissue function, as compared to a larger lesion near bowel treated to lower doses (B).
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Page 7 of 9presence of uncertainties, with larger differences in
delivered doses expected with more complex IMRT and
hypofractionated radiotherapy[17,19]. Reducing segment
number should reduce some of the negative impact of
these uncertainties. More complex IMRT plans are also
expected to have less dosimetric accuracy than simple
IMRT plans, with uncertainties in delivered doses of up
to 13%[16]. We hypothesize that there will be more con-
cordance between delivered and planned doses with
simple liver IMRT. This would also be broadly applic-
able to other treatments with IMRT where geometric
and dosimetric uncertainties are larger (e.g. lung and
other upper gastrointestinal tract malignancies). Future
work will quantify the changes in delivered doses,
accounting for organ motion and residual setup error, in
simple versus complex IMRT.
Other benefits of using fewer segments in IMRT
include reduced treatment time, associated with
improved patient comfort and less potential for intra-
fraction error, and reduced MUs, resulting in less leaf
leakage, and potentially less risk of second malignancy
[13]. In this study, reducing the number of segments
reduced the MUs modestly, by 10%, far less than the
two-to-three fold increase in MUs with the use of IMRT
versus CRT, for other sites[13]. None-the-less, this
reduction does improve treatment efficiency[11,27] and
may also reduce risk of intra-fraction geometric uncer-
tainty that can be increased by longer treatment time in
SBRT treatments[28].
Several groups are exploring other methods to reduce
IMRT complexity including use of planning algorithms
to control number of segments, size and weighting
while optimizing the beam intensity (i.e. direct aperture
optimization)[21], allowing similar plan quality while
using fewer segment numbers. Other methods used to
reduce IMRT complexity include IMRT plan optimiza-
tion using hybrid CRT/IMRT treatments[29], algorithms
to smooth intended radiation fluence[30], and use of
modulation penalty cost functions[31]. However these
methods may be more difficult to implement in clinical
practise. Determining and accounting for geometric
uncertainty (i.e. multiple instance geometric approxima-
tion)[32] within IMRT planning may eventually allow
for plans that are more robust to geometric uncertain-
ties. Finally, minimization of residual uncertainties, with
IGRT and breathing motion management, is a recom-
mended strategy to reduce the potential discrepancy
between planned and delivered doses, in simple and
complex IMRT. Given the rapid advances in technology
in radiotherapy delivery, that facilitate delivery of highly
conformal radiation therapy, there is a need for well
controlled prospective studies to be performed to evalu-
ate the potential benefits or detriments of new technolo-
gies and altered fractionations, particularly with respects
to the accuracy of the dose delivered, requirements for
plan quality assurance and potential toxicities. Given the
uncertainties of complex IMRT dose delivery in the
liver, the current standard practice at our centre for
clinical liver IMRT plans is to aim to use less than 20
beam segments per plan.
Conclusions
Reducing the number of beam segments is a simple
strategy widely available to reduce cancer IMRT plan
complexity. Reducing number of beam segments can be
performed without a significant detriment in target cov-
e r a g eo rn o r m a lt i s s u es p a r i n gf o rl i v e rI M R Tf o rt h e
majority of patients. Reduction of complexity did lead to
a reduction in plan conformity without exceeding nor-
mal tissue dose objectives. The impact of using fewer
beam segments on IMRT plan robustness to residual
geometric uncertainties will be investigated in future
studies.
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